Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
You’re forgetting the CEO has already told us that the platform is validated. We all know you and Derek are trying to establish a ‘ P2 is when this moves’ narrative. I suspect to give your duster of another share time to mature. I’m just setting it straight that this could move any day on a deal landing for the validated platform. Like I’ve said before, leave us fools to it and see you during P2.
This looks to be the company William Bachovchin founded to move forward ava3996 and 6000. I presume he then realised the work needed to push them though all the preclinical and clinical work and decided to license it to Avacta.
No Derek my point is that many of the ADC deals going through for huge sums of money are for sales way in the future . 2026 is near term in the Pharma world. Listen to Novartis CEO talking yesterday, they plan over decades not weeks and months. Get it?
Https://www.fiercebiotech.com/biotech/jpm24-lilly-ceo-david-ricks-biotechs-were-open-business
This article suggests slightly different. For a platform or pipeline, price tag isn’t an issue
Donkey, I’d have thought they might have signed an agreement not to talk to media during the trial or their ongoing treatment, I’m sure they wouldn’t want to jeopardise their on going Chemo by doing so. It’ll come, it’s just a matter of patience and enrolling more patients
Exactly Ice, patients in C4 and 5 that continue to have stable disease or tumour shrinkage will now be going way past where their life expectancy would have been on dox. C6 and c7 will be heading that way, with hope
No hard feelings Thompi, since then I’ve really enjoyed watching Ophidians relevance in the conversation diminish, with his toys frequently flying out the pram in all directions. His recent deification of Hurst and the riddles have been particularly amusing.
Hi Mark, I did nothing more than tell him to stop being so obnoxious, but the manner by which myself and a couple of others copped it rather than him, showed Alberts colours. It’s no skin off my nose and I only mention it as it showed a distinct biased selection process to the group which raised my suspicions somewhat. I do appreciate your updates from the group and your email contacts with AS though, thanks.
I was thinking the ‘very large tumour shrinkage’ was likely to be from C5 Jive, so my fingers are crossed for further patients responding very well in C6 and indications of C7 patients heading in the same direction, this would be dynamite for them and fireworks for us